ArticleBMC cancer2024

Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer.

Zheng-Jun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.